Catalyst Wire Dossier Catalyst Wire Dossier

rhNGF eye drops solution

recombinant human nerve growth factor · Dompé Farmaceutici S.p.A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhNGF eye drops solution, covering 2020-11-25 to 2020-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma [Phase 1]

See pricing